Application 219859
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 25MG | No | No |
| 002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 50MG | No | No |
| 003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219859-001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219859-001 | AB |
| A219859-002 | AB |
| A219859-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | XLCare Pharmaceuticals, Inc. | 20421665-0401-4f6e-9e1d-232c654efb0f | 2023-01-17 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 8015c22c-d944-4a49-8721-70d0c1b98526 | 2022-10-18 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 5b1f6677-9473-467f-9fb6-efadbd8828e8 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | c0319153-3e35-4a84-aa63-935b1e0047d8 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 1b3c03e8-da8e-4c25-a493-118e760a003b | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | aeb4ce44-ab34-4f0e-a674-de42d404d104 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | Proficient Rx LP | e8075254-cdfd-44f3-a9c2-1ed913f846ea | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 50 mg | LOSARTAN POTASSIUM | Proficient Rx LP | f260f7c5-a55b-4294-ae02-2586929e24c9 | 2021-08-01 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 435c5544-491b-476a-b950-712b2c18e334 | 2020-12-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 2f738295-53d6-4d4f-8864-9faf893dbdf2 | 2020-10-07 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | be2432ba-2118-418a-addf-56db9b6c39d2 | 2020-10-07 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losortan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 364fe10e-11ca-4ee6-9f67-c85dec09aca5 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 44050993-c20e-45d4-baeb-f77d91296168 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 35e3472a-457f-4f95-a78d-dbff2595171d | 2019-01-21 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 1f55aaa2-5848-47e0-bba0-6a70b2fa05dd | 2018-12-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 3bcbcb6c-ee8d-44b1-9c78-92712291e891 | 2018-10-15 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 8081b9f8-0b52-46dd-93f2-6bc608b75339 | 2018-07-09 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.